DLDina M. Lotfy

Dina M. Lotfy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dina M. Lotfy has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Heba M. Karam

    Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt

    3 shared publications
  • Amira Abd-ElRaouf

    Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt

    2 shared publications
  • Ayman A. Ibrahim

    Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt

    2 shared publications
  • Farag M. Mosallam

    Drug Radiation Research Department, Drug Microbiology Lab, Biotechnology Division, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt

    2 shared publications
  • Sahar S. Abdelrahman

    Anatomic Pathology Department, Faculty of Veterinary medicine, Cairo University, Cairo, Egypt

    2 shared publications
  • Abeer Bishr

    Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Role of mitophagy in acute and fractionated gamma radiation–induced nephropathy in rats: insight into molecular biology and repurposing of rosuvastatin

    by Noha A. Fadel, Dina M. Lotfy, Asmaa A. Gomaa, Abeer Bishr

    Radiotherapy is crucial in curative oncology, but normal tissue injuries, such as the kidney, restrict its usage. While rosuvastatin (ROSU) is experimentally known to mitigate renal damage, its potential role in protecting against radiation-induced nephrotoxicity has never been investigated. Accordingly, the current study explored the ROSU’s protective impact against radiation-induced nephropathy, with a particular focus on mitophagy regulation. Animals were exposed to 8 Gray (Gy) of whole-body gamma irradiation, either acute or fractionated (2 Gy × 4), and received ROSU (10 mg/kg, i.p.) pre- and post-radiation. Kidney injury was assessed by estimating kidney functions, oxidative stress parameters, and histopathological alterations. To elucidate the mechanism of ROSU, the gene and protein expression of sirtuin 1 (SIRT1) and forkhead box class O (FOXO3a) were estimated, alongside mitophagy and apoptotic biomarkers. Radiation exposure induced cellular necrosis and apoptosis, impaired renal function, and oxidative imbalance. ROSU treatment markedly ameliorated these alterations, demonstrating potent antioxidant activity, as evidenced by reduced malondialdehyde (MDA) level and elevated reduced glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) levels. Mechanistically, ROSU activated SIRT1 and promoted FOXO3a deacetylation, thereby restoring radiation-impaired mitophagy, as indicated by increased expression of PTEN-induced putative kinase protein 1 (PINK1), Parkinson protein 2 E3 ubiquitin protein ligase (Parkin), and autophagy-related gene 5 (ATG5). This was accompanied by the suppression of intrinsic apoptosis triggered by radiation, as shown by decreased cleaved caspase-3 expression. This study repurposes ROSU in modulating radiation-induced nephropathy, revealing its novel role in redirecting cell fate from apoptosis toward mitophagy through SIRT1/FOXO3a activation.


  • Open Access

    Correction to: A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway

    by Heba M. Karam, Dina M. Lotfy, Ayman A. Ibrahim, Farag M. Mosallam, Sahar S. Abdelrahman, Amira Abd-ElRaouf

  • Open Access

    A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway

    by Heba M. Karam, Dina M. Lotfy, Ayman A. Ibrahim, Farag M. Mosallam, Sahar S. Abdelrahman, Amira Abd-ElRaouf

    The present work investigates the potential role of metformin nanoparticles (MTF-NPs) as a radio-protector against cardiac fibrosis and inflammation induced by gamma radiation via CXCL1/TGF-β pathway. Lethal dose fifty of nano-metformin was determined in mice, then 21 rats (male albino) were equally divided into three groups: normal control (G1), irradiated control (G2), and MTF-NPs + IRR (G3). The possible protective effect of MTF-NPs is illustrated via decreasing cardiac contents of troponin, C-X-C motif Ligand 1 (CXCL1), tumor growth factor β (TGF-β), protein kinase B (AKT), and nuclear factor-κB (NF-κB). Also, the positive effect of MTF-NPs on insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) in heart tissues using immunohistochemical technique is illustrated in the present study. Histopathological examination emphasizes the biochemical findings. The current investigation suggests that MTF-NPs might be considered as a potent novel treatment for the management of cardiac fibrosis and inflammation in patients who receive radiotherapy or workers who may be exposed to gamma radiation. Graphical Abstract


  • Open Access

    Ipomoea carnea mitigates ethanol-induced ulcers in irradiated rats via Nrf2/HO−1 pathway: an in vivo and in silico study

    by Mosad A. Ghareeb, Hala Sh. Mohammed, Tarek Aboushousha, Dina M. Lotfy, Maha A. M. El-Shazly, Mansour Sobeh, Eman F. S. Taha

    The aim of this study was to investigate the potential of Ipomoea carnea flower methanolic extract (ICME) as a natural gastroprotective therapy against ethanol-induced gastric ulcers, particularly in individuals exposed to ionizing radiation (IR). The study focused on the Nrf2/HO−1 signaling pathway, which plays a crucial role in protecting the gastrointestinal mucosa from oxidative stress and inflammation. Male Wistar rats were divided into nine groups, the control group received distilled water orally for one week, while other groups were treated with ethanol to induce stomach ulcers, IR exposure, omeprazole, and different doses of ICME in combination with ethanol and/or IR. The study conducted comprehensive analyses, including LC-HRESI-MS/MS, to characterize the phenolic contents of ICME. Additionally, the Nrf2/HO−1 pathway, oxidative stress parameters, gastric pH, and histopathological changes were examined. The results showed that rats treated with IR and/or ethanol exhibited histopathological alterations, increased lipid peroxidation, decreased antioxidant enzyme activity, and reduced expression levels of Nrf2 and HO−1. However, pretreatment with ICME significantly improved these parameters. Phytochemical analysis identified 39 compounds in ICME, with flavonoids, hydroxybenzoic acids, and fatty acids as the predominant compounds. Virtual screening and molecular dynamics simulations suggested that ICME may protect against gastric ulceration by inhibiting oxidative stress and inflammatory mediators. In conclusion, this study demonstrates the potential of ICME as a natural gastroprotective therapy for preventing gastric ulcers. These findings contribute to the development of novel interventions for gastrointestinal disorders using natural plant extracts particularly in individuals with a history of radiation exposure.


  • Nrf2 and NF‐қB interplay in tamoxifen‐induced hepatic toxicity: A promising therapeutic approach of sildenafil and low‐dose γ radiation

    by Heba M. Karam, Shereen M. Galal, Dina M. Lotfy

    Tamoxifen‐induced hepatotoxicity is an inevitable side effect during breast cancer treatment. Low‐dose gamma irradiation (IRR) shows many beneficial effects by stimulating various biological processes. This study evaluates the possible effect of sildenafil and low‐dose gamma radiation on liver damages as new treatment strategies. Group I (control), group II: (tamoxifen), group III: (tamoxifen + Sildenafil), group IV: (tamoxifen+ irradiation) and group V: (tamoxifen +Sildenafil + irradiation). Rats were sacrificed after 5 h from tamoxifen injection. Results showed that tamoxifen caused elevation in serum AST, ALT and ALP as well hepatic ROS, iNOS, MDA, Keap‐1 and NF‐Kb, in addition to diminution in hepatic Nrf2 and HO‐1. Exposure to low‐dose gamma radiation and sildenafil amended the alterations in the measured parameters in serum and tissue. Moreover, all results were confirmed by histopathological examination. In conclusion, sildenafil and low‐dose gamma radiation can mitigate the toxicity induced by tamoxifen in liver tissues. Hence, this treatment could be further evaluated as a new approach for alleviating various liver disorders.